Doxorubicin Market to Receive Overwhelming Hike in Revenues by 2024
The drug is used in combination with other drugs to treat cancers such as, breast, lung, bladder, stomach, ovarian, neuroblastoma, Hodgkin and non-Hodgkin lymphomas, and certain types of leukemia's. It is less commonly used in treatment of squamous cell carcinomas of head and neck, cervix and vagina, carcinomas of testes and prostate. The drug kills the cancerous cells in several ways including intercalation between DNA pairs thereby preventing replication of cancer cells, DNA strand breakage and inhibition with enzyme topoisomerase...
View full press release